MedTrace Logo

NIPS to Identify High-risk Patients With ICD

NCT02373306 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-10-26

No results posted yet for this study

Summary

Implantable cardioverter-defibrillator (ICD) is a widely used and effective therapy which reduces the risk of cardiac death in many cardiac diseases, both implanted for secondary and primary prevention. It is known that recurrent arrhythmias and ICD discharges have adverse prognostic significance. Parameters that would identify patients who are at increased risk of arrhythmias and appropriate ICD interventions would be of clinical value. The aim of the study is to evaluate the usefulness of non-invasive programmed stimulation (NIPS) in determining the likelihood of life-threatening arrhythmic events in patients with ICD.

Conditions

  • Malignant Arrhythmia

Interventions

PROCEDURE

Sustained or hemodynamically unstable arrhythmia induction during non-invasive programmed stimulation

Sponsors & Collaborators

  • St. Joseph's Centre, Poland

    lead OTHER

Principal Investigators

  • Piotr Kułakowski, MD, PhD, FESC · Postgraduate Medical School, Warsaw

  • Piotr Futyma, MD · St. Joseph's Centre, Rzeszów

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02373306 on ClinicalTrials.gov